Cellectis S.A. Operating Expenses 2011-2026 | CLLS

Annual Operating Expenses Cellectis S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
109 M	106 M	115 M	142 M	102 M	147 M	127 M	126 M	105 M	82.9 M	29 M	67.1 M	51.9 M	42.8 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
147 M	29 M	96.6 M

Quarterly Operating Expenses Cellectis S.A.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	52.1 M	-	-	-	37.6 M	-	-	-	38.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
52.1 M	37.6 M	42.6 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Biogen BIIB	5.39 B	$ 172.65	0.62 %	$ 25.1 B	USA
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
BioNTech SE BNTX	512 M	$ 117.22	1.07 %	$ 27.2 B	Germany
Aptorum Group Limited APM	20.7 M	$ 0.98	1.35 %	$ 5.34 M	China
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.62	1.91 %	$ 8.71 B	Australia
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Catalyst Biosciences CBIO	176 M	$ 12.1	-5.47 %	$ 797 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
BioXcel Therapeutics BTAI	107 M	$ 1.78	-2.47 %	$ 4.51 M	USA
BioLineRx Ltd. BLRX	28.1 M	$ 3.05	-1.77 %	$ 908 M	Israel
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Ascendis Pharma A/S ASND	338 M	$ 232.9	-1.06 %	$ 5 B	Danmark
Burford Capital Limited BUR	106 M	$ 9.73	-0.21 %	$ 1.57 B	Britain
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Arrowhead Pharmaceuticals ARWR	731 M	$ 67.14	0.13 %	$ 8.98 B	USA
Compugen Ltd. CGEN	40.4 M	$ 2.05	-1.91 %	$ 184 M	Israel
Can-Fite BioPharma Ltd. CANF	14 M	$ 4.4	-2.87 %	$ 9.57 B	Israel
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	209 M	-	-	$ 1.01 B	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Adaptimmune Therapeutics plc ADAP	141 M	-	-15.15 %	$ 60.3 M	Britain
Amphastar Pharmaceuticals AMPH	168 M	$ 26.56	2.45 %	$ 1.29 B	USA
Coherus BioSciences CHRS	231 M	$ 2.25	9.22 %	$ 212 M	USA
Amneal Pharmaceuticals AMRX	539 M	$ 13.58	1.42 %	$ 4.2 B	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Aptose Biosciences APTO	26.3 M	-	-45.71 %	$ 1.2 M	Canada
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Celldex Therapeutics CLDX	58.1 M	$ 26.54	2.41 %	$ 1.71 M	USA
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	53.7 M	$ 2.75	1.84 %	$ 17.3 M	USA
AstraZeneca PLC AZN	17.6 B	$ 94.2	1.34 %	$ 96.9 B	Britain
Arena Pharmaceuticals ARNA	427 M	-	-6.81 %	$ 3.04 B	USA
Brickell Biotech BBI	14.4 M	-	-5.38 %	$ 6.06 M	USA